These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19461430)

  • 1. Antenatal magnesium sulfate and neurologic outcome in preterm infants: a systematic review.
    Doyle LW; Crowther CA; Middleton P; Marret S
    Obstet Gynecol; 2009 Jun; 113(6):1327-1333. PubMed ID: 19461430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
    Doyle LW; Crowther CA; Middleton P; Marret S
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004661. PubMed ID: 17636771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
    Doyle LW; Crowther CA; Middleton P; Marret S; Rouse D
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004661. PubMed ID: 19160238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.
    Crowther CA; Hiller JE; Doyle LW; Haslam RR;
    JAMA; 2003 Nov; 290(20):2669-76. PubMed ID: 14645308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis.
    Crowther CA; Middleton PF; Voysey M; Askie L; Duley L; Pryde PG; Marret S; Doyle LW;
    PLoS Med; 2017 Oct; 14(10):e1002398. PubMed ID: 28976987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis.
    Costantine MM; Weiner SJ;
    Obstet Gynecol; 2009 Aug; 114(2 Pt 1):354-364. PubMed ID: 19622997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antenatal magnesium sulfate and neuroprotection.
    Doyle LW
    Curr Opin Pediatr; 2012 Apr; 24(2):154-9. PubMed ID: 22227787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No. 376-Magnesium Sulphate for Fetal Neuroprotection.
    Magee LA; De Silva DA; Sawchuck D; Synnes A; von Dadelszen P
    J Obstet Gynaecol Can; 2019 Apr; 41(4):505-522. PubMed ID: 30879485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection.
    Magee L; Sawchuck D; Synnes A; von Dadelszen P; ;
    J Obstet Gynaecol Can; 2011 May; 33(5):516-529. PubMed ID: 21639972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnesium sulphate for women at term for neuroprotection of the fetus.
    Nguyen TM; Crowther CA; Wilkinson D; Bain E
    Cochrane Database Syst Rev; 2013 Feb; (2):CD009395. PubMed ID: 23450601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnesium Sulfate Before Preterm Birth for Neuroprotection: An Updated Cochrane Systematic Review.
    Shepherd ES; Goldsmith S; Doyle LW; Middleton P; Marret S; Rouse DJ; Pryde P; Wolf HT; Crowther CA
    Obstet Gynecol; 2024 Aug; 144(2):161-170. PubMed ID: 38830233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis.
    Conde-Agudelo A; Romero R
    Am J Obstet Gynecol; 2009 Jun; 200(6):595-609. PubMed ID: 19482113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroprotection for preterm infants with antenatal magnesium sulphate].
    Marret S; Ancel PY
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1418-1433. PubMed ID: 28166926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo.
    Doyle LW; Anderson PJ; Haslam R; Lee KJ; Crowther C;
    JAMA; 2014 Sep; 312(11):1105-13. PubMed ID: 25226476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of cerebral palsy using magnesium sulfate in pre-term newborns].
    Marret S; Chollat C; Levèque C; Marpeau L
    Arch Pediatr; 2011 Mar; 18(3):324-30. PubMed ID: 21257296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial].
    Marret S; Marpeau L; Follet-Bouhamed C; Cambonie G; Astruc D; Delaporte B; Bruel H; Guillois B; Pinquier D; Zupan-Simunek V; Bénichou J;
    Gynecol Obstet Fertil; 2008 Mar; 36(3):278-88. PubMed ID: 18337147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antenatal magnesium sulphate neuroprotection in the preterm infant.
    Marret S; Doyle LW; Crowther CA; Middleton P
    Semin Fetal Neonatal Med; 2007 Aug; 12(4):311-7. PubMed ID: 17513184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnesium sulphate for preventing preterm birth in threatened preterm labour.
    Crowther CA; Hiller JE; Doyle LW
    Cochrane Database Syst Rev; 2002; (4):CD001060. PubMed ID: 12519550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal exposure to magnesium sulfate and neuroprotection in preterm infants.
    Costantine MM; Drever N
    Obstet Gynecol Clin North Am; 2011 Jun; 38(2):351-66, xi. PubMed ID: 21575805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of antenatal magnesium sulfate application on cord blood levels of brain-derived neurotrophic factor in premature infants.
    Bachnas MA; Mose JC; Effendi JS; Andonotopo W
    J Perinat Med; 2014 Jan; 42(1):129-34. PubMed ID: 24062546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.